Correvio Pharma Corporation
0.00 (0.0%)


Draw Mode:

Volume 0
Bid Price 0.4311
Ask Price 0.35
News -
Company Name Stock Ticker Symbol Market Type
Correvio Pharma Corporation CORV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.4199 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.4199 0.4199
Trades Volume Avg Volume
0 0 -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.4199 USD

Correvio Pharma Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 27.79M 66.19M 29.00M $ 32.63M $ - -0.46 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

Correvio Pharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No CORV Message Board. Create One! See More Posts on CORV Message Board See More Message Board Posts

Historical CORV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

Correvio Pharma Description

Correvio Pharma Corp is specialty pharmaceutical company. It offers patients and healthcare providers therapeutic solutions for acute medical conditions to improve health and quality of life. Its products are Aggrastat, Esmocard, Brinavess, Xydalba, Zevtera/Mabelio, and others. It offers solutions on Acute Bacterial Skin and Skin Structure Infections, Acute Coronary Syndromes, Atrial Fibrillation, Hospital Acquired Pneumonia & Community Acquired Pneumonia, Pulmonary Arterial Hypertension, and Supraventricular Tachycardia. The firm earns revenue from the sale of company's commercialized products. It has Europe and Rest of the world geographic segments.